CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
Jan. 26, 2015—MicroRNAs, the small noncoding RNA 18-24 nucleotides in length that post-transcriptionally regulate gene regulation, are taking on a larger role in biomarker discovery, diagnostic development, and therapeutic target development.
In this Jan. 27 webinar, a senior scientist at life science firm Promega will discuss a novel chemistry the company developed to simplify and improve the process of isolating MicroRNAs. The presentation begins at 11 a.m. CST. Register.